In the 13 patients without germline alteration, several gene panels for hereditary cancer syndromes were used, all including BRCA1, BRCA2, CHEK2, Partner And Localizer Of BRCA2 (PALB2) and Tumor Protein P53 (TP53). The gene discussed is BRCA2; the disease is Inherited cancer-predisposing syndrome.